Sepimostat
Alternative Names: FUT 187; TO 187Latest Information Update: 20 Oct 2006
At a glance
- Originator Taiho Pharmaceutical; Torii Pharmaceutical
- Class Anti-inflammatories; Antiulcers; Benzoic acids
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatitis; Reflux oesophagitis
Most Recent Events
- 18 Dec 2000 Profile reviewed but no significant changes made
- 08 Sep 1997 A study has been added to the pharmacokinetics section, to the Digestive System Disorders pharmacodynamics and Peptic Ulcer Disease therapeutic trials sections
- 05 Sep 1997 Sepimostat is being investigated for use in pancreatitis